Brief: Hookipa Pharma Announces Leadership Changes To Intensify Focus On HB-200
22/07/2024 13:38
July 22 (Reuters) - Arvinas Inc ARVN.O :
* HOOKIPA PHARMA ANNOUNCES LEADERSHIP CHANGES TO INTENSIFY
FOCUS
ON HB-200
* HOOKIPA PHARMA INC - DR. MALTE PETERS NAMED CEO AT HOOKIPA
* HOOKIPA PHARMA INC - TERRY COELHO APPOINTED EVP AND CFO AT
HOOKIPA
* HOOKIPA PHARMA : SEAN CASSIDY APPOINTED TO BOARD OF
DIRECTORS
Source text for Eikon: ID:nGNX5pWq9g
Further company coverage: ARVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)